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Aldosterone increases sodium reabsorption across kidney
target tubules already before it increases the number of
transport proteins, indicating that the early functional
response to aldosterone depends on the activation of
preexisting channels and pumps. A central mediator of this
action is the early aldosterone-induced kinase Sgk1 that de-
represses the surface expression and activity of the epithelial
sodium channel (ENaC). A main mechanism by which Sgk1
exerts this de-repression is the phosphorylation of the
ubiquitin ligase Nedd4-2 that is thereby prevented from
ubiquitylating ENaC. Among a series of new early
aldosterone-induced gene products recently identified in
kidney target tubules, an additional regulator of ENaC
ubiquitylation, the deubiquitylating enzyme Usp2-45, was
identified. Coexpression of Usp2-45 was shown to increase
ENaC surface expression and activity, and to decrease its
ubiquitylation in expression systems, whereas other Usps
such as the splice variant Usp2-69 had no effect. Since both
Sgk1 and Usp2-45 are similarly induced in distal colon as
well, in contrast to other gene products strongly induced in
kidney that are not regulated in colon, we suggest that
(de)ubiquitylation is the major ENaC regulatory mechanism
targeted by aldosterone in the short-term via transcriptional
regulation.
Kidney International (2008) 73, 691–696; doi:10.1038/sj.ki.5002737;
published online 19 December 2007
KEYWORDS: gene expression microarray; mouse kidney cortical collecting
duct; transepithelial sodium transport; ubiquitin; Usp2-45; SGK
SODIUM TRANSPORT REGULATION BY ALDOSTERONE IN
ASDN: FUNCTIONAL ASPECTS
The mineralocorticoid hormone aldosterone has a short half-
life, and its level follows the circadian rhythm and also
rapidly fluctuates with homeostatic needs. Its best known
effect is to increase sodium reabsorption across target
epithelia expressing the epithelial sodium channel (ENaC),
the mineralocorticoid receptor (MR), and the ‘glucocorti-
coid-protective’ enzyme 11b-hydroxysteroid dehydrogenase
type 2, as it is the case in the aldosterone-sensitive distal
nephron (ASDN).1 The electrogenic sodium reabsorption
mediated by luminal ENaC and the basolateral Na,K-ATPase
starts increasing in ASDN within 30 min of aldosterone
addition. Depending on the physiological conditions and on
the regulatory state of WNK4, electric neutrality of the
transepithelial sodium transport is maintained to a variable
extent by co-reabsorption of Cl (NaCl reabsorption) and/or
Kþ secretion (Naþ /Kþ exchange).1,2
This review focuses on the mechanism that governs the
early regulation of sodium reabsorption by aldosterone. As
discussed below, it appears that the main intracellular
signaling system targeted by aldosterone in the short term
is an ubiquitylation pathway that otherwise exerts a tonic
inhibition on ENaC functional surface expression.3,4 When
the aldosterone stimulation persists for a longer time,
additional regulatory actions develop.1 This does not mean
that the short-term activation mechanism is then inter-
rupted, but that additional effects are taking place that might
on the one hand strengthen the response, and, on the other
hand, as anabolic action, reinforce the machinery in view of
long-term transport activity. Such an aldosterone-induced
differentiation of ASDN cells expressing ENaC-mediated
Naþ reabsorption has been observed morphologically many
years ago and shown to depend not only on the presence of
aldosterone but also on a number of other factors, one of
which is the availability of Naþ in the tubular lumen.5,6
Earlier studies aiming at understanding how aldosterone
induces an increase in Naþ transport across its kidney target
cells followed a candidate approach and focused on the
transport proteins ENaC and Na,K-ATPase and on elements
of the energy metabolism.7,8 That both the luminal channel
ENaC and the basolateral pump Na,K-ATPase are indeed
regulated by aldosterone has been verified, but these
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anabolic-type effects were shown to belong to a slightly
delayed action, although they are, to some extent, initiated
immediately by changes in the transcription rate of some of
the genes encoding these transport proteins.7
The so-called early effects of aldosterone have attracted
much interest also, because they are more amenable to
mechanistic studies than many long-term effects. A great
technical advantage is the lack of overlap of their early start
with potential secondary effects. However, a complication
that has to be taken in account is the fact that aldosterone
apparently also exerts so-called nongenomic effects the
nature of which is apparently multiple, involving potential
direct effects, membrane receptor(s), the MR, and MR-
associated proteins.9 In the next section, we will briefly
review aldosterone-induced gene products that have been
identified and studied in the past years, and, in later sections,
we will focus on the ubiquitylation–deubiquitylation pathway
that regulates ENaC surface expression with particular
emphasis on the aldosterone-regulated players: Sgk1 that
inhibits the function of the ENaC ubiquitin ligase Nedd4-2
and Usp2-45, a newly identified deubiquitylating enzyme that
targets ENaC (Figure 1).
PREVIOUSLY IDENTIFIED EARLY ALDOSTERONE-REGULATED
GENE PRODUCTS ACTING ON THE ION TRANSPORTING
MACHINERY
The classical mechanism by which aldosterone acts in its
target cells is by activating the MR that belongs to the family
of nuclear receptors. In particular, its stimulatory action on
Naþ reabsorption in kidney distal nephron has indeed been
shown to mostly depend on transcriptional regulation,
whereas other actions appear to be independent of
transcriptional regulation.1,9 Over the past decade, a number
of gene products that are induced by aldosterone have been
identified, mostly in cell culture systems, and, in some cases,
a possible role in mediating the early aldosterone-induced
increase in sodium reabsorption has been shown experimen-
tally, generally using expression systems.
Clearly, the most studied and apparently central player is
Sgk1, a kinase belonging to the AGC family of serine/
threonine protein kinases that similar to Akt/protein kinase B
needs to be itself activated via 3-phosphoinositide-dependent
kinases PDK1 and 2. Sgk1 has been identified first in cultured
cells and its regulation has been verified in vivo in kidney
ASDN and distal colon.10,11 A short section will be dedicated
to this important player that interferes with the ENaC
ubiquitylation pathway.
The first early aldosterone-induced gene product that was
identified and shown in an expression system to stimulate the
function of ENaC is K-Ras2.12 It has to be mentioned that it
was identified in an amphibian model cell line (A6), and that
its early regulation by aldosterone was not verified in mouse
kidney target tubules but in mouse distal colon.13 In any case,
this small G protein via its effector protein PI3-kinase
stimulates ENaC activity via the PDK–Sgk pathway (Figure 1
and see below) and possibly also via direct effects of its
phospholipid product PI(3,4,5)P on ENaC function.14
Another aldosterone-regulated gene product that has been
identified in cell culture and the induction of which has
been verified in kidney tubule is GILZ, a member of the
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Figure 1 | Model for the early transcriptional action of aldosterone on ENaC function. The ubiquitin ligase Nedd4-2 that tonically
inhibits ENaC surface expression is highlighted in red, and red dashed arrows indicate pathways downregulating ENaC that are antagonized
by aldosterone. Blue boxes represent the regulatory proteins implicated in the early aldosterone action that are rapidly induced via
activated MR. The blue lines terminated by a dash indicate at what level these regulatory proteins interfere with ENaC inhibition.
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TSC22 family of leucine zipper proteins.15 This gene product
has been shown to prevent activation of Raf, another
downstream effector of Ras, and thereby to prevent
the inhibitory action of Erk1/2 on ENaC.16 Interestingly,
Erk-mediated inhibition of ENaC appears to involve channel
phosphorylation that stimulates interaction with Nedd4
ubiquitin ligases (Figure 1). Thus, the stimulatory action of
GILZ on ENaC activity is mediated, similar to that of Sgk1,
by the release of ENaC from the tonic inhibition mediated by
Nedd4-2.4
The mechanism of action of the three early aldosterone-
induced proteins mentioned above have been shown to
stimulate ENaC to a large extend by interfering with the tonic
inhibitory action of Nedd4 proteins. Other potential early
aldosterone-induced regulatory proteins acting on ENaC
function are for instance 14-3-3 protein isoforms b and e that
participate in the inhibition of Nedd4-2 mediated by Sgk1
and N-Myc downstream-regulated gene 2 (NDRG2), the
mechanism of action of which has not yet been clarified.17,18
Also, the kidney-specific WNK1 isoform has been shown to
be induced by aldosterone in a cell culture model and might
participate in the aldosterone action on sodium transport.19
ROLE OF Nedd4-2 IN ENaC REGULATION
Epithelial sodium channel has been shown to be regulated
by ubiquitylation (also referred to as ubiquitination or
ubiquitinylation), a posttranslational modification involving
the ligation of (a) ubiquitin polypeptide(s).20 Although
ubiquitylation has originally been recognized as a degrada-
tion signal for cytosolic proteins, it is now clear that this
posttranslational modification plays an essential role in the
regulation of basically any kind of cellular function.
Importantly, ubiquitylation is reversible, and, correspond-
ingly, a large number of different deubiquitylating enzymes
have been identified as well.
Ubiquitylation of target proteins involves an enzymatic
cascade. The first step of this cascade is binding of ubiquitin
by a thioester to a cysteine residue of the E1 ubiquitin-
activating enzyme, a reaction requiring ATP. Ubiquitin is
then transferred onto an E2 enzyme, also as thioester. Finally,
it is an E3 enzyme, or ubiquitin-protein ligase that provides
substrate recognition and promotes transfer of ubiquitin to
the target protein to which it is then linked by an isopeptide
bond at the level of the e-amino group of a lysine residue.
The various E3 enzymes work by one of the two following
mechanisms. Ligases that contain a RING finger motif
promote the direct transfer of ubiquitin from the E2 enzyme
onto the target protein, whereas the so-called HECT domain
containing E3 ligases, to which Nedd4-2 belongs, forms first a
thioester between the ubiquitin and their HECT domain, and
then transfer the ubiquitin onto the target protein. These
targets can be differentially ubiquitylated, for instance
monoubiquitylated (one monoubiquitin), multiubiquitylated
(several monoubiquitins each on a different lysine), or
polyubiquitylated (one or multiple chains of ubiquitins
linked together via internal lysines, mostly K48 and K63).
This differential ubiquitylation allows the generation of a
multitude of different signals.
The fact that ubiquitylation plays a major role for ENaC
regulation was revealed by the investigation of the defect
underlying Liddle’s syndrome. This rare hereditary form of
salt-sensitive hypertension is autosomal dominant and
accompanied by hypokalemia, metabolic acidosis, and low
circulating levels of renin and aldosterone. The increased
sodium reabsorption observed in this condition was shown
to be caused by mutations within the genes encoding b or
gENaC leading to the deletion or mutation of the so-called
PY motif located in the cytoplasmic COOH termini of these
subunits.21 The first evidence that ENaC may be regulated by
ubiquitylation came from the finding that these PY motifs
(xPPxY) act as binding sites for the WW protein–protein
interaction domains of ubiquitin-protein ligases belonging to
the Nedd4/Nedd4-like family, in particular, Nedd4-2.22
Indeed, the work of many laboratories has confirmed that
ENaC is a protein complex with a rapid turnover, which is
ubiquitylated in a Nedd4-2-dependent manner.3 Ubiquityla-
tion by Nedd4-2 decreases ENaC cell surface expression,22
primarily by enhancing its internalization and also by
interfering with its cAMP-dependent translocation to the
surface from a subapical pool and by stimulating its targeting
to the lysosomal/endosomal pathway.23
Several important aspects of this type of regulation have
been described recently. As outlined above, proteins can for
instance be either mono-, multi-, or polyubiquitylated.24
Whereas membrane receptors appear often to be regulated by
monoubiquitylation,25 the case of ENaC is less clear. It
appears that ENaC can be mono or multiubiquitylated,
but also polyubiquitylated.23,26,27 Wiemuth et al.26 chose an
indirect approach to show that an antibody specific for
polyubiquitylation does not detect ubiquitylated species of
ENaC at the cell surface of transfected COS cells, suggesting
that ENaC is either mono or multiubiquitylated at the plasma
membrane. A caveat may be that in these experiments single
ENaC subunits were transfected, and hence, this may not
represent the normal situation for ENaC, that is composed of
three subunits. Another approach has been chosen by Snyder
and collaborators,27 who, in contrast, showed that cell surface
ENaC can be either mono-, multi-, or polyubiquitylated. To
determine if monoubiquitylation is involved in ENaC cell
surface expression, they expressed an ubiquitin variant with
mutated lysine residues that cannot participate in polyubi-
quitylation. This manipulation increased the amount of
bENaC at the cell surface, suggesting that polyubiquitylation
restricts ENaC cell surface expression. On the other hand,
overexpression of Nedd4-2 together with this lysine-less
ubiquitin variant still caused a downregulation of ENaC
activity, suggesting that mono- or multiubiquitylation may
also play a role.
The physiological relevance of the mechanistic questions
discussed above remains to some extent open, since so far, no
knockout model for Nedd4-2 is available. However, direct
evidence for a role of Nedd4-2 was obtained in Fisher rat
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thyroid cells transfected with ENaC subunits, in which RNA
interference experiments demonstrated that suppression of
Nedd4-2, but not of its close paralogue Nedd4-1, causes an
increase in transepithelial Naþ transport.28 Moreover, there
are several genetic studies that associate polymorphisms of
Nedd4-2 with blood pressure variations in human popula-
tion.29–32 Finally, it is apparent that Nedd4-2-dependent
ubiquitylation of ENaC is regulated physiologically by
various mechanisms. For instance, Loffing-Cueni et al.33
showed that varying Naþ diet influences Nedd4-2 expression
in the ASDN. Specifically, low Naþ diet decreases Nedd4-2,
whereas high salt diet increases it. Moreover, it was
shown that the gradient of Nedd4-2 protein expression
that increases along the nephron from CNT toward
CCD is opposite to that of ENaC. The central role played
by Nedd4-2-mediated downregulation of ENaC is demons-
trated by the fact that hormones such as aldosterone and
vasopressin that stimulate Naþ reabsorption actually act by
antagonizing this Nedd4-2-mediated ubiquitylation of
ENaC (Figure 1, see below). A major player for this
Nedd4-2 antagonism is Sgk1 that has been shown to bind
to Nedd4-2 and to phosphorylate it, thereby providing
docking sites for 14-3-3 proteins. The association of these
14-3-3 proteins with Nedd4-2 is then thought to prevent
binding of Nedd4-2 to ENaC, and thereby to cause a
reduction in ENaC ubiquitylation leading to an accumulation
of ENaC at the plasma membrane.34–36 Similar to Sgk1,
PKA,37 GRK2,38,39 and Akt40 are able to phosphorylate Nedd4-2,
showing that this ubiquitin ligase also functions as a site of
regulatory convergence.
Sgk1: A POINT OF REGULATORY CONVERGENCE
The early aldosterone-induced protein Sgk1 is a ubiquitous
kinase that has been shown to target directly or indirectly the
function of many other transport proteins, besides its Nedd4-
2-mediated action on ENaC mentioned above.41 In the
context of aldosterone action, it is noteworthy to mention
that Sgk1 has recently been shown to also increase aENaC
transcription by inhibiting histone methylation in its
promoter region.42 Despite these important roles in mediat-
ing the effect of aldosterone on ENaC, Sgk1 knockout mice
are viable and present normal blood pressure and kidney
function when fed normal diet.43 That Sgk1 nonetheless plays
a regulatory role in these conditions is indicated by a slightly
elevated aldosterone level. The fact that Sgk1 plays a crucial
role for compensating a low Naþ intake was shown by the
fact that Sgk1 knockout mice display decreased blood
pressure and glomerular filtration rate under low Naþ diet
conditions. The kidney phenotype of these mice being much
less severe than that of the MR knockout mice confirms that
Sgk1 is not the only mediator through which aldosterone
stimulates and supports Naþ reabsorption. For the short-
term regulation of ENaC function, it appears, however, to
play a central role within the regulatory network, by
integrating inputs from different regulatory pathways
and translating them into a graded release of ENaC from
Nedd4-2-mediated inhibition. Sgk1 is regulated on the one
hand at the level of its transcription, in particular, by
aldosterone via MR, and also by other hormones such as
glucocorticoids. On the other hand, it is regulated at the level
of its function by its phosphorylation, in particular, by the
PDK kinases that mediate stimulatory effects of hormones
such as IGF and insulin that stimulate the PI3-kinase
pathway, and possibly also by PKA that mediates the effect
of hormones such as vasopressin (antidiuretic hormone)
(Figure 1).44,45 Thus, transcriptional and posttranslational
regulations of Sgk1 act synergistically. An other less
well-understood aspect of the control of Sgk1 function is
its subcellular localization for which posttranslational
modifications such as phosphorylation and interactions with
other proteins also certainly play an important role.46
Usp2-45: A NEW ALDOSTERONE-INDUCED PLAYER
In a recent gene expression screen performed on mouse
kidney connecting/collecting ducts, Fakitsas et al.47 identified
nine mRNAs that increased Xtwofold after 1 h aldosterone.
Among these they identified, next to Sgk1, also the ubiquitin-
specific protease Usp2-45. This deubiquitylating enzyme was
shown in Xenopus oocytes to increase the function of
coexpressed ENaC at the cell surface, whereas other tested
deubuquitylating enzymes, such as its isoform Usp2-69 had
no effect. Interestingly, the stimulatory effect of Usp2-45 was
at least as important as that of Sgk1 but not additive to it.
This, as well as the observations that Usp2-45 was not
increasing the function of ENaC devoid of COOH-terminal
PY motif (binding site for Nedd4-2) nor that of ENaC devoid
of NH2-terminal lysine residues (potential ubiquitylation
sites), suggests that Usp2-45 interferes with the same Nedd4-
2-dependent ubiquitylation as Sgk1. Furthermore, using
HEK293 cells, the same authors showed that Usp2-45
coexpression strongly decreases the level of ENaC ubiquityla-
tion. Thus, aldosterone also increases the deubiquitylation of
ENaC. The question remains open whether Usp2-45 by
deubiquitylating ENaC, and possibly interacting with it plays
additional roles in the regulation of this channel. It may
particularly play a major role in conditions in which
aldosterone is high, but the Nedd4-2 inhibitory function of
Sgk1 is not stimulated due to low activity of the PI3-kinase
and cAMP pathways.
CONCLUSIONS AND PERSPECTIVES
There is an ongoing increase in the number of newly
published mechanisms and regulatory cross talks that impact
on the function of ENaC, not only confirming that this
channel plays a central role for the regulation of Naþ
reabsorption in aldosterone target epithelia, but also
supporting the notion that this homeostatically important
function is controlled by an intricate network encompassing
a great number of pathways that are controlled by a myriad of
local, regional, and organismic inputs. The inputs that
impact on Naþ transport via ENaC in the short term appear
to converge onto a dominating repressor system that involves
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ENaC ubiquitylation and deubiquitylation. An important
argument supporting this view is the observation that among
the gene products rapidly and substantially upregulated by
aldosterone in kidney and in distal colon, Sgk1 and Usp2-45
are the ones with the strongest early regulation and appear to
be the only ones directly involved in regulating Naþ
transport function (Fakitsas P, Wagner U, and Verrey F,
unpublished data).47 Importantly, by controlling the level of
key regulatory proteins of ENaC ubiquitylation/deubiquity-
lation, aldosterone sets the level of sensitivity of the Naþ
transport machinery to the inputs of other signaling path-
ways, in particular mediated by PI3-kinase (IGF, insulin),
cAMP (vasopressin), and ERK (Figure 1).
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